| 摘要 |
There is disclosed a process for determining early patient response to an initial therapy administration, comprising a rapid determination of effectiveness of a therapy after an initial treatment for a cancer indication. There is further disclosed a process for determining early patient response to an initial cancer treatment, comprising (a) conducting a baseline PET FDG or PET FL T scan of the tumor region in a patient by determining tumor tissue metabolic rate and/or apoptotic rate (for FLT), (b) providing a single potentially effective dose of a therapeutic to the patient, (c) conducting a second PET FDG or PET FLT scan by determining tumor tissue metabolic rate, and (d) comparing the results of the first PET scan to the second PET scan to determine an imaging response in the PET scan results. |
